Related Experiment Videos
Opioid peptides as drug products: FDA regulatory requirements
NIDA Research Monograph
|January 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Development of delta opioid peptides as nonaddicting analgesics.
Pharmaceutical research·1991
The molecular basis of cannabinoid activity.
Life sciences·1990
Synthesis and biological properties of 4-norleucine-neuropeptide Y; secondary structure of neuropeptide Y.
Biochimica et biophysica acta·1989
Aluminum in parenteral products: overview of chemistry concerns and regulatory actions.
Journal of parenteral science and technology : a publication of the Parenteral Drug Association·1989
Dynorphin A (1-13) peptide NH groups are solvent exposed: FT-IR and 500 MHz 1H NMR spectroscopic evidence.
Biochemical and biophysical research communications·1988
Substance abuse vulnerability in offspring of alcohol and drug abusers.
NIDA research monograph·1998
Navigating Therapeutic Frontiers: A Meta-review and Meta-analysis of COVID-19 Treatment Options.
Journal of research in pharmacy practice·2026
Population-level benefits of correctional medications for opioid use disorder.
Journal of substance use and addiction treatment·2026
Opioid-Sparing Sedation for Gastrostomy Tube Placement: A Retrospective Cohort Study Comparing Ketamine/Midazolam and Fentanyl/Midazolam.
Journal of vascular and interventional radiology : JVIR·2026
People who use drugs as frontline responders: Rethinking overdose response training through lived experience.
The International journal on drug policy·2026
Inhibition of PARP1-mediated parthanatos by rucaparib phosphate alleviates sepsis-induced acute lung injury.
International immunopharmacology·2026